Gyre Therapeutics Competitors and Similar CompaniesClear all

Gyre Therapeutics's competitors and similar companies include Idogen, Zaluvida, Cord Blood Registry and Cook MyoSite.

	Gyre Therapeutics Gyre Therapeutics (formerly known as Catalyst Biosciences) is a drug R&D company creating catalytic biopharmaceutical products based on engineered human proteases.	Idogen Idogen is a biotechnology company that develops tolerogenic cell therapies.	Zaluvida Zaluvida is a provider of healthcare solutions.	Cord Blood Registry Cord Blood Registry (CBR) is a company that specializes in the clinical application of cord blood and tissue stem cells.	Cook MyoSite Cook MyoSite is a biotechnology company specializing in the regenerative medicine industry.
Founding Date	Founding Date 2003	Founding Date 2008	Founding Date 2005	Founding Date 1992	Founding Date 2002
Type	Type Public	Type Public	Type Private	Type Subsidiary	Type Subsidiary
Tags	Tags Healthcare biotech life sciences therapy	Tags Healthcare biotech life sciences therapy	Tags Healthcare biotech life sciences therapy	Tags Healthcare biotech clinical research medical diagnostics	Tags Healthcare biotech life sciences therapy
Locations	Locations South San Francisco, US HQ	Locations Lund, SE HQ	Locations Kuala Lumpur, MY HQ Singapore, SG Rolle, CH	Locations Los Angeles, US HQ Tucson, US Chicago, US	Locations Pittsburgh, US HQ
Employees	Employees 3462% increase	Employees 10	Employees 6	Employees 169	Employees 1961% decrease
Valuation ($)	Valuation ($) 19.4 m	Valuation ($) 1.2 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $116.6m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $5.4m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $111.2m (FY, 2025)	Gross profit kr272k (FY, 2022)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income $9.9m (FY, 2025)	Net income (kr47.8m) (FY, 2022)	Net income N/A	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 30m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 18m	Total funding raised N/A